血小板通过TGF-β信号通路促进卵巢癌细胞侵袭并诱导上皮间质转化
该研究纳入69例卵巢癌患者、16例良性卵巢肿瘤患者和64例健康供者血样,并用血小板处理SK-OV-3和OVCAR-3卵巢癌细胞。结果显示血小板计数升高的卵巢癌患者晚期比例更高,血小板处理增强两种细胞侵袭性并诱导上皮间质转化(EMT),TβR I抑制剂A83-01可逆转上述改变并抑制血小板诱导的侵袭。结论认为血小板经TGF-β依赖通路增强侵袭并诱导EMT,血小板来源TGF-β可能作为卵巢癌新靶点。
要点
- 血小板计数升高的卵巢癌患者晚期阶段发生率更高。
- 血小板处理上调间质标志物、下调上皮标志物并增强卵巢癌细胞侵袭。
- TβR I抑制剂A83-01可逆转EMT样改变并抑制血小板诱导的侵袭。
核心结论
- 血小板经TGF-β依赖通路增强卵巢癌细胞侵袭潜能并诱导EMT。
- 血小板来源TGF-β可能作为卵巢癌的新靶点治疗。
研究设计与样本
- 采集69例卵巢癌患者、16例良性卵巢肿瘤患者和64例健康供者的血样进行临床数据分析。
- 用血小板处理SK-OV-3和OVCAR-3卵巢癌细胞,通过Transwell实验分析侵袭能力。
- 通过微阵列分析、qPCR和Western blotting评估EMT,通过ELISA和Western blotting检测TGF-β通路激活。
- 使用TGF-β I型受体(TβR I)抑制剂A83-01在体外和体内验证TGF-β通路的作用。
主要发现
- 临床数据显示血小板计数升高的卵巢癌患者晚期阶段发生率更高。
- 血小板处理增强SK-OV-3和OVCAR-3两种细胞系的侵袭特性。
- 血小板处理细胞中间质标志物Snail家族转录抑制因子-1、波形蛋白、神经钙黏蛋白、纤连蛋白-1和基质金属蛋白酶-2上调,上皮标志物上皮钙黏蛋白下调。
- 血小板计数升高的患者TGF-β水平高于对照对象,血小板处理的培养基中TGF-β水平升高,血小板处理细胞中Smad2磷酸化增加。
- TβR I抑制剂A83-01在体外和体内逆转EMT样改变并抑制血小板诱导的侵袭。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test whether platelets could increase invasion potential and initiate EMT in ovarian cancer cells via a TGF-β signaling pathway. METHODS: Blood samples were collected in 69 patients with ovarian cancer, 16 patients with benign ovarian tumor and 64 healthy donors. SK-OV-3 and OVCAR-3 ovarian cancer cells were treated with platelets. Transwell assays were used to analyze the invasive capacity, and EMT was assessed by microarray analysis, quantitative real-time PCR (qPCR) and Western blotting. Activation of TGF-β pathway was examined by ELISA and Western blotting. TGF-β type I receptor (TβR I) inhibitor A83-01 was used to confirm the role of TGF-β pathway in vitro and in vivo. RESULTS: Clinical data showed ovarian cancer patients with elevated platelet counts had a higher incidence of advanced stages. Treatment with platelets increased the invasive properties of both cell lines. Mesenchymal markers (snail family transcriptional repressor-1, vimentin, neural cadherin, fibronectin-1 and matrix metalloproteinase-2) were up-regulated in platelet-treated cells, while the epithelial marker (epithelial cadherin) was down-regulated. Higher TGF-β level was observed in patients with elevated platelet counts when compared to the subjects. Higher levels of TGF-β were also found in culture medium treated with platelets, and cells treated with platelets also showed increased phosphorylation of Smad2. TβR I inhibitor A83-01 reversed the EMT-like alterations and inhibited platelet-induced invasion in vitro and in vivo. CONCLUSION: Platelet increased invasion potential and induced EMT in ovarian cancer cells in a TGF-β dependent pathway. Platelet-derived TGF-β may be useful as a new target treatment for ovarian cancer.
引用
- Guo Y, Cui W, Pei Y, et al. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway. Gynecol Oncol. 2019. PMID: 30928020. doi:10.1016/j.ygyno.2019.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。